News | Breast Imaging | November 07, 2016

Results show VolparaDensity grades provide more consistent readings

mammography, VolparaDensity grades, breast density, fibroglandular breast density, Radboud University Medical Center, Netherlands study

November 7, 2016 — Researchers from the Netherlands recently completed a study that explored the variation between radiologists when judging fibroglandular breast density visually on serially-acquired mammograms, and whether an automated density assessment would provide better consistency. Results of the study, “Consistency of breast density categories in serial screening mammograms: A comparison between automated and human assessment,” recently published in the Breast Journal, suggest that an automated computer measurement, VolparaDensity, provides better consistency than density readings performed visually by radiologists.

In the study, Katharina Holland and a team from the Radboud University Medical Center in The Netherlands, investigated the categorization of pairs of subsequent screening mammograms into density classes by human readers and by an automated breast density assessment system. One thousand mammograms belonging to 500 pairs of subsequent screening exams were randomly selected from the Dutch breast screening program. The serial mammograms, which had an average 30-month interval between them, were categorized into either two-category (“fatty” versus “dense”) or a four-category (BI-RADS 4th Edition: 1, 2, 3 or 4) density classes by four readers, including three specialized breast radiologists, and by using Volpara Density Grades (VDG), which are analogous to the BI-RADS (Breast Imaging-Reporting and Data System) density categories.

In addition, to better replicate clinical practice, a “group reading” was performed. In these group readings, each mammogram set was scored by randomly selecting one of the four radiologists’ scores and assigning it to the study; the intention here was to emulate the fact that serial mammograms are usually read by different radiologists.

Volpara identified a significantly higher percentage of women who did not exhibit a change between two-point density categories (90.4 percent) compared to the group reading of radiologists (86.8 percent). Volpara’s agreement to its own readings between serial exams was significantly higher than the group radiologist readings were to each other. Volpara maintained higher kappa agreement values on both two- and four- category scales, prompting researchers to suggest that Volpara produced more consistent density readings than the radiologists.

When women did exhibit a density change between screens, most of the instances of change were from the “dense” to “fatty” category (this happened in approximately 70 percent of cases of density change). Change in the other direction (“dense” to “fatty”) occurred as well, though less frequently — this could potentially be caused by use of hormone replacement therapy, weight loss or measurement error. There was no significant difference between the direction of density change between Volpara measurements and those of the radiologists.

Overall, the indication was that an automated computer measurement such as Volpara provides better consistency than density readings done by radiologists, when emulating clinical screening practice. “These results are particularly important given the recent work presented by Sprague et al. The use of an automated density measurement algorithm could prove desirable in screening practice — not only because of improved efficiency in terms of time and cost, but also because of enhanced reliability. Furthermore, the results indicate that Volpara could prove useful in temporal measurements of breast density,” noted Prof. Nico Karssemeijer, Radboud University Nijmegen. “These could be valuable for examining breast cancer risk, by looking at the occurrence of age-related involution or looking at response to adjuvant or neoadjuvant hormonal therapy, which can be reflected in breast density.”

For more information: www.onlinelibrary.wiley.com


Related Content

News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Feature | Radiology Business

The ITN team wishes you a safe and happy 4th of July!

Time July 04, 2024
arrow
Subscribe Now